BeiGene Ltd (BGNE)
190.51
-4.05
(-2.08%)
USD |
NASDAQ |
Nov 22, 16:00
190.50
0.00 (0.00%)
After-Hours: 20:00
BeiGene Price to Book Value: 5.911 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 5.911 |
| November 21, 2024 | 6.037 |
| November 20, 2024 | 6.028 |
| November 19, 2024 | 5.826 |
| November 18, 2024 | 5.824 |
| November 15, 2024 | 5.872 |
| November 14, 2024 | 5.998 |
| November 13, 2024 | 6.065 |
| November 12, 2024 | 6.008 |
| November 11, 2024 | 6.362 |
| November 08, 2024 | 6.376 |
| November 07, 2024 | 6.417 |
| November 06, 2024 | 6.290 |
| November 05, 2024 | 6.455 |
| November 04, 2024 | 6.431 |
| November 01, 2024 | 6.336 |
| October 31, 2024 | 6.266 |
| October 30, 2024 | 6.367 |
| October 29, 2024 | 6.692 |
| October 28, 2024 | 6.713 |
| October 25, 2024 | 6.577 |
| October 24, 2024 | 6.618 |
| October 23, 2024 | 6.830 |
| October 22, 2024 | 6.819 |
| October 21, 2024 | 6.797 |
| Date | Value |
|---|---|
| October 18, 2024 | 6.767 |
| October 17, 2024 | 6.564 |
| October 16, 2024 | 6.866 |
| October 15, 2024 | 6.880 |
| October 14, 2024 | 7.017 |
| October 11, 2024 | 7.297 |
| October 10, 2024 | 7.398 |
| October 09, 2024 | 7.430 |
| October 08, 2024 | 7.276 |
| October 07, 2024 | 7.510 |
| October 04, 2024 | 7.604 |
| October 03, 2024 | 7.221 |
| October 02, 2024 | 7.219 |
| October 01, 2024 | 7.138 |
| September 30, 2024 | 6.938 |
| September 27, 2024 | 6.883 |
| September 26, 2024 | 6.697 |
| September 25, 2024 | 6.514 |
| September 24, 2024 | 6.596 |
| September 23, 2024 | 6.344 |
| September 20, 2024 | 6.365 |
| September 19, 2024 | 6.258 |
| September 18, 2024 | 6.217 |
| September 17, 2024 | 6.224 |
| September 16, 2024 | 6.190 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.123
Minimum
May 11 2022
13.96
Maximum
Feb 19 2020
6.186
Average
5.618
Median
Price to Book Value Benchmarks
| Theravance Biopharma Inc | 2.508 |
| Labcorp Holdings Inc | 2.454 |
| Merck & Co Inc | 5.638 |
| Bristol-Myers Squibb Co | 6.965 |
| Zai Lab Ltd | 4.254 |
Price to Book Value Related Metrics
| PS Ratio | 6.016 |
| Price | 190.51 |
| Earnings Yield | -4.37% |
| Market Cap | 20.31B |